Dr. White is a native of New York and trained in chemistry at the State University of New York at Albany , and attended medical school at Albert Einstein College of Medicine in the Bronx , graduating in 1975. He did his post-graduate pediatric and pediatric endocrinology training at St. Louis Children’s Hospital and Washington University in St. Louis and then served as an Assistant Professor of Pediatrics in the Division of Endocrinology and Metabolism from 1980-1987.
From 1987 to 1991, he served as Associate Professor of Pediatrics and Communicable Diseases at the University of Michigan School of Medicine, and as Associate Director of the Clinical Implementation Core of the Michigan Diabetes Research and Training Center . Dr. White returned to Washington University in 1991 and is currently a Professor in the Division of Endocrinology and Metabolism. He is also Co-Unit Leader of the of the Department of Pediatrics, Director of the Pediatric Diabetes Registry of the Washington University , and Program Director (with responsibilities for the pediatric unit) of the Washington University Pediatric Clinical Research Center . He is board certified in pediatrics and pediatric endocrinology and is a Certified Diabetes Educator (CDE).
Dr. White is a member of multiple professional societies including the Professional Section of the American Diabetes Association, the American Federation for Medical Research, the Lawson Wilkins Pediatric Endocrine Society, the Society for Pediatric Research, the American Pediatric Society, the International Society for Pediatric and Adolescent Diabetes, the Endocrine Society, the International Diabetes Federation, and the Juvenile Diabetes Research Foundation. He has had a longstanding involvement with the American Diabetes Association at the local, state, regional, and national level and has served on many boards and committees. These have included his involvement as a member of the Research Grant Review Panel, the Scientific Sessions Planning Committee, and the Camp Task Force of the American Diabetes Association (ADA), and as Program Chairman and subsequently Chairman of the Council on Diabetes in Youth of the ADA . He is the immediate Past-President of the St. Louis Chapter of the American Diabetes Association. Dr. White has also had an 20 year involvement in the organization and operation of camps for diabetic children and was the recipient of the award for Outstanding Contribution to Diabetes and Camping of the American Diabetes Association in 1998.
Over the last 20 years, Dr. White’s research interests have included active participation as a co-investigator and subsequently co-principal investigator of the Diabetes Control and Complications Trial (DCCT) both at Washington University and the University of Michigan . He has had an ongoing interest in the methods of intensive therapy in type 1 and the risk of hypoglycemia as part of this therapy. He has recently completed a trial to determine whether intensive diabetes therapy initiated at the time of diagnosis can prevent or slow the progression of beta cell loss in newly-diagnosed diabetic children and a randomized, controlled trial of intensive diabetes therapy in children; the aim of this latter study was to determine factors that predict success or failure of intensive diabetes therapy in children and evaluate the risk of hypoglycemia in diabetic children. He also oversees the Diabetes Prevention Program (DPP), multiple trials of psychosocial interventions in diabetic teenagers, and the local centers of the Type 1 Diabetes TrialNet and TRIGR studies (related to prevention of type 1 diabetes) and the STOPP-T2D/TODAY study (related to treatment and prevention of type 2 diabetes in youth).
Recently, Dr. White has been collaborating with , from the Department of Psychiatry to study cognitive functioning in children with type 1 diabetes mellitus. These studies have consistently shown persistent effects of severe hypoglycemia on the long delay Spatial Delayed Response Task (SDR) and suggest an affect of prior hypoglycemia on memory function. Studies are continuing in hopes of confirming and expanding these findings. See for more information.
Dr. White is supported largely by research grants from NIH and JDRF grant on intensive therapy for children with IDDM. He is also supported by the General Clinical Research Center grant, and various grants from pharmaceutical companies.